Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma

This study has been completed.

Sponsor:

Collaborators:

Sanofi-Synthelabo

Hoffmann-La Roche

Information provided by:

Austrian Breast & Colorectal Cancer Study Group

ClinicalTrials.gov Identifier:

NCT00297141

First received: February 27, 2006

Last updated: January 19, 2007

Last verified: February 2006

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	March 2006
Estimated Primary Completion Date:	No date given

No publications provided by Austrian Breast & Colorectal Cancer Study Group

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ofner D, Devries AF, Schaberl-Moser R, Greil R, Rabl H, Tschmelitsch J, Zitt M, Kapp KS, Fastner G, Keil F, Eisterer W, Jäger R, Offner F, Gnant M, Thaler J; TAKO 05/ABCSG R-02 Trial Investigators. Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT?NxM0, low rectal cancer: a phase II study. Strahlenther Onkol. 2011 Feb;187(2):100-7. Epub 2011 Jan 21.

To Top